Cargando…
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
BACKGROUND: The tyrosine kinase Src is involved in the progression of many cancers. Moreover, inhibiting Src activity has been shown to obstruct several signaling pathways regulated by the EGFR. Thus, Src is a valuable target molecule in drug development. The purpose of this study was to identify co...
Autores principales: | Lai, Yi-Hua, Lin, Sih-Yin, Wu, Yu-Shan, Chen, Huei-Wen, Chen, Jeremy J. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683468/ https://www.ncbi.nlm.nih.gov/pubmed/29132432 http://dx.doi.org/10.1186/s13045-017-0539-3 |
Ejemplares similares
-
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways
por: Lai, Yi-Hua, et al.
Publicado: (2015) -
Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling
por: Bieerkehazhi, Shayahati, et al.
Publicado: (2016) -
The potential of Src inhibitors
por: Elias, Daniel, et al.
Publicado: (2015) -
Structural and functional characterization of the divergent Entamoeba Src using Src inhibitor-1
por: López-Contreras, Luilli, et al.
Publicado: (2017) -
Mitotic Activation of c‐Src Is Suppressed by Csk
por: Ohsato, Yoshiharu, et al.
Publicado: (1994)